Mifepristone ruling means a huge fight ahead
On May 14, the U.S. Supreme Court “kicked the can down the road” on medical abortion, saving some votes for Trump cronies in the mid-term elections but signaling to the rest of us that tele-health prescribing of mifepristone remains in danger. The Court decided that a lower-court decision from Louisiana that required patients, including those living in states with complete abortion bans, to visit a doctor’s office to get a mifepristone prescription would remain “paused.” In the meantime, the issue would continue to be litigated in the lower courts and the part of the Republican base that remains pro-abortion would not be stirred up before voting. This maneuver has allowed the high court to expediently delay, but be ready use its powers to further erode the availability of reproductive health care when it is more politically convenient.



















